 OakBend Introduces Revolutionary Treatment for Varicose Veins
|
|
Richmond, Texas - August 1, 2006
- It is estimated that varicose veins affect a significant proportion
of the population - 40% of women and 25% of men. Good news is at hand
for those requiring treatment - OakBend Medical Center has invested in
Endovenous Laser Treatment (EVLT) which removes unattractive varicose
veins, requires no hospital stay, no lengthy recovery, has no
side-effects but, best of all, there is no scarring. In less than an
hour patients can be free from bulging, twisted varicose veins and back
to enjoying everyday activities. EVLT provides a safe, fast, and
effective treatment.
The
physician uses ultrasound to map out the patient’s vein, applies a
local anesthetic and a thin laser fiber is inserted through a tiny
entry point, usually near the knee. Laser energy is delivered to seal
the faulty vein. The patient is encouraged to walk immediately after
the procedure and can resume normal daily activity, avoiding only
rigorous activities such as gym workouts. The patient may experience
minor soreness and bruising which can be treated with over-the-counter,
non-aspirin pain relievers as necessary.
To
compliment EVLT, OakBend Medical Center has also invested in the very
latest non-invasive technology for locating spider and varicose veins.
The patented Luminetx VeinViewer™ makes veins visible to the naked eye
by projecting real-time images of the exact location of veins directly
onto the skin. Acclaimed by Time Magazine as “one of the most amazing
medical inventions of the year,” the VeinViewer™ allows healthcare
providers to quickly and accurately map a patient’s veins for a variety of procedures, regardless of age, gender, body type or skin tone.
Phu
Do, M.D. says “this new technology has revolutionized the way we treat
patients with varicose veins, the complications and possible
side-effects from surgical ligation and stripping have virtually
disappeared. Outcomes are far better with little or no side-effects”.
For further information contact: Tracey J. Shaw
VP, Marketing & Development
281-238-7821